glp 1 pharmacology Current Insights, Advantages and Challenges of Small Molecule Glucagon-like Peptide Receptor Agonists: A Scoping Review Recent updates on GLP-1 agonists:

While gastrointestinal side effects are common, they are generally mild and transient, especially with proper patient education and dose titration

GLP-1 medications create the conditions for change, but lasting success depends on adopting healthier habits

This is an FDA-approved branded product, not compounded semaglutide

If the Court adopts Lillys reading, defendants may be positioned to pursue early dispositive motion practice on warning and preemption grounds across a materially broader set of claimed injuries

The Group Insurance Commission which provides health coverage to public employees, retirees, and their families also limited GLP-1 coverage